The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.
Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of age in September and submitted the trial data to the Drugs and Comptroller General of India (DCGI) at the start of this month.
What it means for children and parents on emergency approval of vaccine take a look. India Today spoke to 8-year-old Ishanvi Samdani and her parents who shared their perspectives on vaccination for kids.

#CovidVaccineForKids #Covaxin #6PMPrime #IndiaToday


Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

Follow us: Official website: [ Ссылка ]

Twitter: [ Ссылка ]

Facebook: [ Ссылка ]

Telegram: [ Ссылка ]

свернуть